SCHEMBL8166386

SCHEMBL8166386

Cc1cccc(C=C2SC(=S)NC2=S)c1

nearest known ligand 0.74

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAT1 P18440 3/20 0.74
PIM1 P11309 1/20 0.56
PIM2 Q9P1W9 1/20 0.56
GSK3B P49841 1/20 0.55
ADAMTS5 Q9UNA0 2/20 0.51
TDP1 Q9NUW8 3/20 0.50
CISD1 Q9NZ45 2/20 0.50
PNP P00491 1/20 0.50
CA2 P00918 1/20 0.46
EPHX1 P07099 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
MMP3 P08254 1/20 0.46
MMP13 P45452 1/20 0.46
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8166383 1.00 NAT1 (0.74) NAT1PIM1PIM2GSK3BADAMTS5
SCHEMBL7557614 0.85 NAT1 (1.00) NAT1PIM1PIM2GSK3BADAMTS5
SCHEMBL7557609 0.85 NAT1 (1.00) NAT1PIM1PIM2GSK3BADAMTS5
SCHEMBL8189394 0.81 ADAMTS5 (0.78) NAT1GSK3BADAMTS5TDP1MMP3
SCHEMBL8189396 0.81 ADAMTS5 (0.78) NAT1GSK3BADAMTS5TDP1MMP3
SCHEMBL29825140 0.78 CISD1 (0.76) NAT1PIM1PIM2ADAMTS5TDP1
SCHEMBL8172626 0.73 MEN1 (0.73) NAT1PIM1PIM2GSK3BTDP1
SCHEMBL8172622 0.73 MEN1 (0.73) NAT1PIM1PIM2GSK3BTDP1
SCHEMBL8189119 0.72 ALDH1A1 (0.41) NAT1GSK3BADAMTS5TDP1CISD1
SCHEMBL8189117 0.72 ALDH1A1 (0.41) NAT1GSK3BADAMTS5TDP1CISD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed